Proangiogenic microtemplated fibrin scaffolds containing aprotinin promote improved wound healing responses

[1]  D. Bull,et al.  Aprotinin and preservation of myocardial function after ischemia-reperfusion injury. , 2003, The Annals of thoracic surgery.

[2]  Dougald M Monroe,et al.  What does it take to make the perfect clot? , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[3]  A. Waggoner,et al.  Immobilization of aprotinin to fibrinogen as a novel method for controlling degradation of fibrin gels. , 2007, Bioconjugate chemistry.

[4]  P. Carmona,et al.  Raman study of the thermal behaviour and conformational stability of basic pancreatic trypsin inhibitor , 2003, European Biophysics Journal.

[5]  P. Jurasz,et al.  Generation of platelet angiostatin mediated by urokinase plasminogen activator: effects on angiogenesis , 2006, Journal of thrombosis and haemostasis : JTH.

[6]  J. Lotz,et al.  Biological and Biomechanical Effects of Fibrin Injection Into Porcine Intervertebral Discs , 2011, Spine.

[7]  S. Reeves,et al.  Aprotinin exerts differential and dose-dependent effects on myocardial contractility, oxidative stress, and cytokine release after ischemia-reperfusion. , 2008, The Annals of thoracic surgery.

[8]  Stuart K Williams,et al.  Angiogenesis and neovascularization associated with extracellular matrix-modified porous implants. , 2002, Journal of biomedical materials research.

[9]  S. Cook,et al.  Hydrogel-based engineered skeletal muscle grafts normalize heart function early after myocardial infarction. , 2008, Artificial organs.

[10]  M. Hincke,et al.  Fibrin: a versatile scaffold for tissue engineering applications. , 2008, Tissue engineering. Part B, Reviews.

[11]  Buddy D Ratner,et al.  Prevascularized microtemplated fibrin scaffolds for cardiac tissue engineering applications. , 2013, Tissue engineering. Part A.

[12]  Julie H. Campbell,et al.  The Fibrotic Response to Implanted Biomaterials: Implications for Tissue Engineering , 2011 .

[13]  S. Reeves,et al.  Aprotinin in Cardiac Surgery: A Review of Conventional and Novel Mechanisms of Action , 2007, Anesthesia and analgesia.

[14]  K. Bendixen,et al.  Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue , 2009, Proceedings of the National Academy of Sciences.

[15]  PhDb,et al.  Effect of aprotinin on endothelial cell activation. , 2001, The Journal of thoracic and cardiovascular surgery.

[16]  W. Thompson,et al.  Angiogenic activity of fibrin degradation products is located in fibrin fragment E , 1992, The Journal of pathology.

[17]  N. Kipshidze,et al.  Transplantation of Autologous Endothelial Cells Induces Angiogenesis , 2003, Pacing and clinical electrophysiology : PACE.

[18]  S. Rennard,et al.  Aprotinin Reduces Interleukin-8 Production and Lung Neutrophil Accumulation After Cardiopulmonary Bypass , 1996, Anesthesia and analgesia.

[19]  Randall J Lee,et al.  Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. , 2004, Tissue engineering.

[20]  C. Lewis,et al.  Fibrin fragment E stimulates the proliferation, migration and differentiation of human microvascular endothelial cells in vitro , 2004, Angiogenesis.

[21]  H. Fritz,et al.  Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. , 1983, Arzneimittel-Forschung.

[22]  George P McCabe,et al.  Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component. , 2009, Biomaterials.

[23]  P. Koolwijk,et al.  Aprotinin stimulates angiogenesis and human endothelial cell migration through the growth factor pleiotrophin and its receptor protein tyrosine phosphatase beta/zeta. , 2009, European journal of pharmacology.

[24]  T. Okano,et al.  Reproducible subcutaneous transplantation of cell sheets into recipient mice , 2011, Nature Protocols.

[25]  Randall J Lee,et al.  Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. , 2004, Journal of the American College of Cardiology.

[26]  P. Jurasz,et al.  Temporal and Pharmacological Characterization of Angiostatin Release and Generation by Human Platelets: Implications for Endothelial Cell Migration , 2013, PloS one.

[27]  G. Hill,et al.  Aprotinin enhances the endogenous release of interleukin-10 after cardiac operations. , 1998, The Annals of thoracic surgery.

[28]  Charles E. Murry,et al.  Growth of Engineered Human Myocardium With Mechanical Loading and Vascular Coculture , 2011, Circulation research.

[29]  Lauran R. Madden,et al.  Proangiogenic scaffolds as functional templates for cardiac tissue engineering , 2010, Proceedings of the National Academy of Sciences.

[30]  Israel Nur,et al.  A comparison of the mechanical, kinetic, and biochemical properties of fibrin clots formed with two different fibrin sealants , 2011, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[31]  A. Logan,et al.  Angiogenesis , 1993, The Lancet.

[32]  Yen-Chih Huang,et al.  Contractile three-dimensional bioengineered heart muscle for myocardial regeneration. , 2007, Journal of biomedical materials research. Part A.

[33]  S Jockenhoevel,et al.  Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[34]  G. Crépin,et al.  Mechanical properties of synthetic implants used in the repair of prolapse and urinary incontinence in women: which is the ideal material? , 2003, International Urogynecology Journal.

[35]  Hojjat Naderi,et al.  Review paper: Critical Issues in Tissue Engineering: Biomaterials, Cell Sources, Angiogenesis, and Drug Delivery Systems , 2011, Journal of biomaterials applications.

[36]  P. Koolwijk,et al.  Role of Fibrin Matrix in Angiogenesis , 2001, Annals of the New York Academy of Sciences.

[37]  A. Malik,et al.  Fibrinogen degradation product fragment D increases endothelial monolayer permeability. , 1991, The American journal of physiology.

[38]  Seung‐Woo Cho,et al.  Implantation of bone marrow mononuclear cells using injectable fibrin matrix enhances neovascularization in infarcted myocardium. , 2005, Biomaterials.

[39]  Steven C George,et al.  Prevascularization of a fibrin-based tissue construct accelerates the formation of functional anastomosis with host vasculature. , 2009, Tissue engineering. Part A.

[40]  May Griffith,et al.  Characterization and inhibition of fibrin hydrogel-degrading enzymes during development of tissue engineering scaffolds. , 2007, Tissue engineering.

[41]  J. Hubbell,et al.  Engineered aprotinin for improved stability of fibrin biomaterials. , 2011, Biomaterials.

[42]  H. Dvorak,et al.  Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[43]  Buddy D Ratner,et al.  Engineering biomaterials to integrate and heal: The biocompatibility paradigm shifts , 2012, Biotechnology and bioengineering.

[44]  James M. Anderson,et al.  Biological Responses to Materials , 2001 .

[45]  Buddy D. Ratner,et al.  A fibrinogen-based precision microporous scaffold for tissue engineering. , 2007, Biomaterials.

[46]  A. Balbarini,et al.  Fibrin as a scaffold for cardiac tissue engineering , 2011, Biotechnology and applied biochemistry.

[47]  L. Lindbom,et al.  Non-homogeneous blood flow distribution in the rabbit tenuissimus muscle. Differential control of total blood flow and capillary perfusion. , 1984, Acta physiologica Scandinavica.

[48]  R. Homer,et al.  Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor β1 , 2001, The Journal of experimental medicine.

[49]  Thomas Schmitz-Rode,et al.  Tranexamic acid--an alternative to aprotinin in fibrin-based cardiovascular tissue engineering. , 2009, Tissue engineering. Part A.

[50]  B J Messmer,et al.  Fibrin gel -- advantages of a new scaffold in cardiovascular tissue engineering. , 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.